Related Experiment Videos
Increased thrombin generation in patients with chronic renal failure
A Sagripanti1, V Cozza, U Baicchi
1Clinical Medicine Institute, University Hospital, Pisa, Italy.
Summary
Prothrombin fragment 1 + 2 (F1 + 2) levels indicate hypercoagulability in chronic kidney disease patients. Higher F1 + 2 levels correlate with reduced kidney function, suggesting increased thrombin generation and vascular event risk.
Area of Science:
- Nephrology
- Hematology
- Clinical Chemistry
Background:
- Chronic uremia is associated with latent hypercoagulability.
- Prothrombin fragment 1 + 2 (F1 + 2) is a sensitive marker for hypercoagulability.
Purpose of the Study:
- To evaluate the degree of hypercoagulation in patients with chronic kidney disease.
- To assess the relationship between F1 + 2 levels and renal function.
- To investigate the mechanism of elevated F1 + 2 in uremia.
Main Methods:
- Plasma F1 + 2 levels were measured using ELISA in 51 patients with chronic renal failure and 33 healthy controls.
- Patients were categorized based on treatment: dietary, hemodialysis (once weekly or maintenance).
- Correlation with serum creatinine and effects of heparin administration were analyzed.
Main Results:
- Plasma F1 + 2 levels were significantly elevated in all patient groups compared to controls.
- F1 + 2 levels increased progressively with the severity of renal failure and hemodialysis frequency.
- A positive correlation was observed between F1 + 2 and serum creatinine in diet-treated patients.
- Heparin administration reduced F1 + 2 levels, indicating accelerated thrombin generation.
- No increase in F1 + 2 was observed during a single hemodialysis session.
Conclusions:
- Elevated plasma F1 + 2 in chronic uremia reflects accelerated in vivo thrombin generation.
- The degree of hypercoagulation is linked to the severity of renal failure.
- Enhanced coagulation activation may contribute to the heightened risk of vascular events in uremic patients.